NYSEIndustrialsIndustrial - MachinerySnapshot 2026-08-31
Reading XYL? Create a free portfolio, then add this holding for ongoing Reports and tracking. Track it in a free portfolio. No credit card.
Create your account →Intact: The reason to own it still holds.
Xylem grows revenue about 4% yearly with steady profit margins near 23%. Free cash flow margin stays strong around 10%. The company buys back shares and beats earnings estimates consistently.
Revenue growth could stall below 3%. Profit margins might shrink due to cost pressures. Free cash flow margin could weaken if capital allocation falters.
The price is about 10% below our fair value near $135. Analysts expect roughly 4% revenue growth, which aligns with our view. Our fair value is 12% below the Street median, reflecting a more cautious outlook.
Breaks if: Fails to beat EPS or cuts guidance in FY26
Breaks if: Free cash flow margin falls below 9% in FY26
Breaks if: Gross margin falls below 22% in FY26
This is not a price target or investment advice.
A long-form read on the 1–3 year hold thesis. It updates when the weekly evidence changes.
This is a durable compounder with a focus on revenue growth and margin expansion. The current thesis state reflects a consistent execution of management priorities, although there are some mixed signals regarding cash flow generation.
The valuation is characterized as cheap compared to peers, with a slight expectations gap. The market seems to have priced in a low level of fragility, indicating that it does not expect significant negative surprises in the near term.
Management is on track to increase revenue and maintain adjusted EBITDA margins, with recent results showing positive momentum. However, there is a moderate risk of missing earnings expectations, which could impact sentiment.
The thesis hinges on the performance of sector bellwethers and management's ability to sustain revenue growth and margins. Any guidance cuts or negative trends from key competitors could pose risks.
The most important moves since the prior daily snapshot.
Mixed, the news cuts both ways. The company beat earnings expectations recently. However, Xylem lowered its revenue outlook for the fiscal year. Analyst sentiment has turned slightly more bearish since last month.
as of 2026-08-31
Review the evidence to watch, what would become a concern, and what would make it less concerning.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Breaks if: YoY revenue growth falls below 3% in FY26
Overall, XYL's fundamentals appear stable, but the investment thesis is sensitive to external sector influences and management execution. Not investment advice.
